首页 > 最新文献

Nihon Toseki Igakkai Zasshi最新文献

英文 中文
Impact of longer-term phosphorus control on aortic arch calcification in hemodialysis patients 长期磷控制对血液透析患者主动脉弓钙化的影响
Pub Date : 2022-01-01 DOI: 10.4009/jsdt.55.635
A. Mizuno
{"title":"Impact of longer-term phosphorus control on aortic arch calcification in hemodialysis patients","authors":"A. Mizuno","doi":"10.4009/jsdt.55.635","DOIUrl":"https://doi.org/10.4009/jsdt.55.635","url":null,"abstract":"","PeriodicalId":19275,"journal":{"name":"Nihon Toseki Igakkai Zasshi","volume":"164 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86413061","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and parameter-kinetics of mac-2 binding protein glycosylation isomer (M2BPGi) and magnetic resonance elastography in hepatitis C patients treated with direct-acting antiviral therapy:A case series of 5 hemodialysis patients mac-2结合蛋白糖基化异构体(M2BPGi)和磁共振弹性成像在丙型肝炎患者直接抗病毒治疗中的疗效和参数动力学:5例血液透析患者的病例系列
Pub Date : 2022-01-01 DOI: 10.4009/jsdt.55.645
Y. Nishizawa, H. Ohno, Ayako Kimura, Eriko Hirasawa, Mai Tosaka, Y. Hosoda, Erika Yamaguchi, Ai Horimoto, Kiyotsugu Omae, K. Tsuchiya, K. Nitta, H. Sakura, T. Ogawa
{"title":"Efficacy and parameter-kinetics of mac-2 binding protein glycosylation isomer (M2BPGi) and magnetic resonance elastography in hepatitis C patients treated with direct-acting antiviral therapy:A case series of 5 hemodialysis patients","authors":"Y. Nishizawa, H. Ohno, Ayako Kimura, Eriko Hirasawa, Mai Tosaka, Y. Hosoda, Erika Yamaguchi, Ai Horimoto, Kiyotsugu Omae, K. Tsuchiya, K. Nitta, H. Sakura, T. Ogawa","doi":"10.4009/jsdt.55.645","DOIUrl":"https://doi.org/10.4009/jsdt.55.645","url":null,"abstract":"","PeriodicalId":19275,"journal":{"name":"Nihon Toseki Igakkai Zasshi","volume":"24 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83253089","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Decrease in neutralizing antibody titers after SARS-CoV-2 vaccination in hemodialysis patients and the booster effect of a third vaccination 血液透析患者接种SARS-CoV-2疫苗后中和抗体滴度下降及第三次接种的增强作用
Pub Date : 2022-01-01 DOI: 10.4009/jsdt.55.589
K. Ooyama, N. Kaneko, Yumiko Kitazumi, Mieko Yokozeki, H. Ooyama, Shin Fujimori
{"title":"Decrease in neutralizing antibody titers after SARS-CoV-2 vaccination in hemodialysis patients and the booster effect of a third vaccination","authors":"K. Ooyama, N. Kaneko, Yumiko Kitazumi, Mieko Yokozeki, H. Ooyama, Shin Fujimori","doi":"10.4009/jsdt.55.589","DOIUrl":"https://doi.org/10.4009/jsdt.55.589","url":null,"abstract":"","PeriodicalId":19275,"journal":{"name":"Nihon Toseki Igakkai Zasshi","volume":"344 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86795880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
新たな中分子量物質分類と血液浄化法の位置づけ 新中分子量物质分类和血液净化法定位
Pub Date : 2022-01-01 DOI: 10.4009/jsdt.55.509
Hideki Kawanishi
{"title":"新たな中分子量物質分類と血液浄化法の位置づけ","authors":"Hideki Kawanishi","doi":"10.4009/jsdt.55.509","DOIUrl":"https://doi.org/10.4009/jsdt.55.509","url":null,"abstract":"","PeriodicalId":19275,"journal":{"name":"Nihon Toseki Igakkai Zasshi","volume":"32 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89960474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
腹膜透析と新型コロナウイルス感染症 腹膜透析和新型冠状病毒感染
Pub Date : 2022-01-01 DOI: 10.4009/jsdt.55.371
歩 吉藤, Munekazu Ryuzaki
新型コロナウイルス感染症(COVID‒19)は2022 年4 月現在,依然として猛威を振るっている.透析患者は重症化のリスクが高く,死亡率も8.8%と一般人口の0.38%と比較して非常に高い.腹膜透析患者も死亡率は9.5%と高い.パンデミックの初期には腹膜透析患者は血液透析患者と比べて罹患率が低く,死亡率も低いことが報告されていたが,日本からの報告では有意差は認めていない.しかし,透析患者は重症化しやすいことには変わりなく,早期診断,早期治療が求められる.抗ウイルス薬や抗炎症薬は透析患者の予後改善に役立つが,腎機能低下の患者では,使用に注意するべき点があり,薬剤の特徴をよく理解した上で使用する必要がある.また,COVID‒19 に罹患しても基本的には腹膜透析を継続することは可能であるが,患者が重症化した場合には,体液量の調節および腹臥位療法の観点から持続的血液濾過透析を考慮することもある.腹膜透析を施行した場合には,排液は感染性があることに留意する.今回われわれが経験したパンデミックは在宅医療の重要性を再認識させられた.患者が腎代替療法を選択する際には,医療従事者は,パンデミックや災害時の観点からの説明も重要である.また,われわれもパンデミックの際に慌てないように遠隔患者管理プログラムなどの情報通信技術を用いて医療体制の構築が求められる.
截至2022年4月,新型冠状病毒感染(COVID - 19)依然来势汹汹。透析患者重症化的风险很高,死亡率为8.8%,与一般人口的0.38%相比非常高。腹膜透析患者的死亡率也高达9.5%。有报道称,在大流行初期,腹膜透析患者的患病率比血液透析患者低,死亡率也低,但来自日本的报告中没有发现显著性差异。但是,透析患者的病情容易恶化,这一点是不变的,因此需要早期诊断,早期治疗。抗病毒药和抗炎药对改善透析患者的预后有帮助,但肾功能低下的患者在使用时应注意,必须在充分了解药物特征的基础上使用。另外,即使罹患COVID - 19,基本上也可以继续进行腹膜透析,但患者病情严重时,从调节体液量及腹卧位疗法的观点考虑持续性血液过滤透析。施行腹膜透析时,注意排液有感染性。这次我们经历的大流感让我们再次认识到家庭医疗的重要性。患者在选择肾替代疗法的时候,医疗工作者,从大流行和灾害时的观点的说明也很重要。此外,我们也需要利用远程患者管理程序等信息通信技术构建医疗体系,以便在流感暴发时不慌乱。
{"title":"腹膜透析と新型コロナウイルス感染症","authors":"歩 吉藤, Munekazu Ryuzaki","doi":"10.4009/jsdt.55.371","DOIUrl":"https://doi.org/10.4009/jsdt.55.371","url":null,"abstract":"新型コロナウイルス感染症(COVID‒19)は2022 年4 月現在,依然として猛威を振るっている.透析患者は重症化のリスクが高く,死亡率も8.8%と一般人口の0.38%と比較して非常に高い.腹膜透析患者も死亡率は9.5%と高い.パンデミックの初期には腹膜透析患者は血液透析患者と比べて罹患率が低く,死亡率も低いことが報告されていたが,日本からの報告では有意差は認めていない.しかし,透析患者は重症化しやすいことには変わりなく,早期診断,早期治療が求められる.抗ウイルス薬や抗炎症薬は透析患者の予後改善に役立つが,腎機能低下の患者では,使用に注意するべき点があり,薬剤の特徴をよく理解した上で使用する必要がある.また,COVID‒19 に罹患しても基本的には腹膜透析を継続することは可能であるが,患者が重症化した場合には,体液量の調節および腹臥位療法の観点から持続的血液濾過透析を考慮することもある.腹膜透析を施行した場合には,排液は感染性があることに留意する.今回われわれが経験したパンデミックは在宅医療の重要性を再認識させられた.患者が腎代替療法を選択する際には,医療従事者は,パンデミックや災害時の観点からの説明も重要である.また,われわれもパンデミックの際に慌てないように遠隔患者管理プログラムなどの情報通信技術を用いて医療体制の構築が求められる.","PeriodicalId":19275,"journal":{"name":"Nihon Toseki Igakkai Zasshi","volume":"32 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"75959877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Questionnaire survey on core outcomes to improve Quality of Life of patients on hemodialysis therapy, and awareness gap between doctors and patients 改善血液透析治疗患者生活质量的核心结局及医患认知差距的问卷调查
Pub Date : 2022-01-01 DOI: 10.4009/jsdt.55.613
Masaaki Nakayama, Y. Miyazawa, Masafumi Fukagawa
{"title":"Questionnaire survey on core outcomes to improve Quality of Life of patients on hemodialysis therapy, and awareness gap between doctors and patients","authors":"Masaaki Nakayama, Y. Miyazawa, Masafumi Fukagawa","doi":"10.4009/jsdt.55.613","DOIUrl":"https://doi.org/10.4009/jsdt.55.613","url":null,"abstract":"","PeriodicalId":19275,"journal":{"name":"Nihon Toseki Igakkai Zasshi","volume":"97 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74077953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Summary of the Okinawa Dialysis Study from 1971 to 2020 (OKIDS50) 1971 - 2020年冲绳透析研究综述(OKIDS50)
Pub Date : 2022-01-01 DOI: 10.4009/jsdt.55.627
K. Iseki, Akira Higa, K. Kohagura
{"title":"Summary of the Okinawa Dialysis Study from 1971 to 2020 (OKIDS50)","authors":"K. Iseki, Akira Higa, K. Kohagura","doi":"10.4009/jsdt.55.627","DOIUrl":"https://doi.org/10.4009/jsdt.55.627","url":null,"abstract":"","PeriodicalId":19275,"journal":{"name":"Nihon Toseki Igakkai Zasshi","volume":"13 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81885703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dialysis therapy, 2021 year in review 透析治疗,2021年回顾
Pub Date : 2022-01-01 DOI: 10.4009/jsdt.55.725
修 脇野, 雅司 友, F. Koiwa
{"title":"Dialysis therapy, 2021 year in review","authors":"修 脇野, 雅司 友, F. Koiwa","doi":"10.4009/jsdt.55.725","DOIUrl":"https://doi.org/10.4009/jsdt.55.725","url":null,"abstract":"","PeriodicalId":19275,"journal":{"name":"Nihon Toseki Igakkai Zasshi","volume":"69 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"83324791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
新型コロナウイルスと血液透析 新型冠状病毒和血液透析
Pub Date : 2022-01-01 DOI: 10.4009/jsdt.55.93
Mariko Miyazaki, 崇 渡邊, 多恵 山本, 裕二 山口, 章 杉浦, 崇 中道, 建文 森, 和久 竹内
{"title":"新型コロナウイルスと血液透析","authors":"Mariko Miyazaki, 崇 渡邊, 多恵 山本, 裕二 山口, 章 杉浦, 崇 中道, 建文 森, 和久 竹内","doi":"10.4009/jsdt.55.93","DOIUrl":"https://doi.org/10.4009/jsdt.55.93","url":null,"abstract":"","PeriodicalId":19275,"journal":{"name":"Nihon Toseki Igakkai Zasshi","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89426350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of colorectal, stomach, and lung cancer in dialysis patients in Osaka Prefecture 大阪府透析患者大肠癌、胃癌和肺癌的治疗
Pub Date : 2022-01-01 DOI: 10.4009/jsdt.55.309
Nanami Kida, T. Morishima, Y. Tsubakihara
{"title":"Treatment of colorectal, stomach, and lung cancer in dialysis patients in Osaka Prefecture","authors":"Nanami Kida, T. Morishima, Y. Tsubakihara","doi":"10.4009/jsdt.55.309","DOIUrl":"https://doi.org/10.4009/jsdt.55.309","url":null,"abstract":"","PeriodicalId":19275,"journal":{"name":"Nihon Toseki Igakkai Zasshi","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"80008555","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Nihon Toseki Igakkai Zasshi
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1